Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • STOXX Changes Composition Of Blue-Chip Indices - Regular Annual Review To Be Effective On Sep. 18, 2017

    Date 31/08/2017

    STOXX Ltd., the operator of Deutsche Boerse Group’s index business, and a global provider of innovative and tradable index concepts, today announced the results of the regular annual review of the STOXX Blue-Chip Indices, among them the STOXX Europe 50EURO STOXX 50 and STOXX Nordic 30 indices; as well as the results of the second semi-annual review of the STOXX Eastern Europe 50 Index. All changes will be effective with the open of European markets on Sep. 18, 2017.

  • FINRA Issues Alert Warning Investors Of Stock Fraud Following Hurricane Harvey

    Date 31/08/2017

    FINRA issued an Investor Alert today warning investors to beware of potential scams touting stocks and other investments promising huge financial gains in the wake of Hurricane Harvey.

  • SEC And NYU to Host Forum On Exchange-Traded Products

    Date 31/08/2017

    The Securities and Exchange Commission and New York University will host a forum in September to examine the fast growing market for exchange-traded products and its implications for investors.

  • CFTC Orders Ikon Global Markets, Inc. To Pay $200,000 For Recordkeeping Violations

    Date 31/08/2017

    The U.S. Commodity Futures Trading Commission (CFTC) today issued an Order filing and simultaneously settling charges against Ikon Global Markets, Inc. (Ikon) for failing to keep and promptly produce documentation for thousands of gold Exchange for Physical (EFP) trades, in violation of the Commodity Exchange Act (CEA) and CFTC Regulations. The trades were entered into by Ikon and reported to the NASDAQ OMX Futures Exchange, Inc. (NFX).

  • SEC: Former Pharma Company Accountant, Three Others Charged With Insider Trading

    Date 31/08/2017

    The Securities and Exchange Commission today charged an accountant and three others with insider trading on market-moving news about the New Jersey-based pharmaceutical company where the accountant formerly worked.